172 related articles for article (PubMed ID: 8633961)
1. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of angiogenesis in operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
[TBL] [Abstract][Full Text] [Related]
4. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract][Full Text] [Related]
6. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
Angeletti CA; Lucchi M; Fontanini G; Mussi A; Chella A; Ribechini A; Vignati S; Bevilacqua G
Cancer; 1996 Aug; 78(3):409-15. PubMed ID: 8697384
[TBL] [Abstract][Full Text] [Related]
11. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
14. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
15. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
[TBL] [Abstract][Full Text] [Related]
16. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
[TBL] [Abstract][Full Text] [Related]
17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
19. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
20. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes.
Sardari Nia P; Colpaert C; Vermeulen P; Weyler J; Pezzella F; Van Schil P; Van Marck E
Ann Thorac Surg; 2008 Feb; 85(2):395-405. PubMed ID: 18222232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
